Inventor · disambiguated record
Zhuozhi Wang
Also filed as: WANG ZHUOZHI
14 granted patents·27 pending applications·41 citations·filing 2008–2025
90Inventor score
Files withBAYER HEALTHCARE LLC15WUXI BIOLOGICS IRELAND LTD12WANG ZHUOZHI4WUXI BIOLOGICS SHANGHAI CO LTD4CSTONE PHARMACEUTICALS3
Top patents by PatentIndex Score
41 records- 0195US11078281B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2020·Granted Aug 3, 2021·8 cites·7 claims
- 0286US11845796B2Bispecific polypeptide complexesWUXI BIOLOGICS IRELAND LTD·Filed 2018·Granted Dec 19, 2023·2 cites·27 claims
- 0384US12240906B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2023·Granted Mar 4, 2025·0 cites·6 claims
- 0484US8481030B2Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)WANG ZHUOZHI·Filed 2011·Granted Jul 9, 2013·12 cites·6 claims
- 0583US11643463B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGIES SHANGHAI CO LTD·Filed 2017·Granted May 9, 2023·3 cites·4 claims
- 0683US9657111B2Humanized monoclonal antibodies against activated protein C and uses thereofBAYER HEALTHCARE LLC·Filed 2013·Granted May 23, 2017·6 cites·19 claims
- 0783US9556280B2Anti-TFPI antibody variants with differential binding across PH range for improved pharmacokineticsBAYER HEALTHCARE LLC·Filed 2014·Granted Jan 31, 2017·4 cites·6 claims
- 0876US9624309B2Monospecific and multispecific antibodies and method of useLIU BING·Filed 2008·Granted Apr 18, 2017·2 cites·38 claims
- 0974US2024124586A1Novel bispecific polypeptide complexesWUXI BIOLOGICS IRELAND LTD·Filed 2023·Application pending·0 cites
- 1073US9309324B2Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)WANG ZHUOZHI·Filed 2011·Granted Apr 12, 2016·3 cites·10 claims
- 1173US2024101676A1The novel monoclonal antibodies to programmed death 1 (pd-1)CSTONE PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 1272US11414487B2Monoclonal antibodies to programmed death 1 (PD-1)CSTONE PHARMACEUTICALS·Filed 2016·Granted Aug 16, 2022·1 cites·18 claims
- 1372US2025163156A1Novel monoclonal antibodies to cytotoxic t-lymphocyte-associated protein 4 (ctla-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 1472US2022041752A1Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)BAYER HEALTHCARE LLC·Filed 2021·Application pending·0 cites
- 1567US2023014722A1Novel Monoclonal Antibodies to Programmed DEATH (PD-1)CSTONE PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 1667US2018194857A1Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)BAYER HEALTHCARE LLC·Filed 2018·Application pending·0 cites
- 1766US2019194353A1Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)BAYER HEALTHCARE LLC·Filed 2018·Application pending·0 cites
- 1865US2025313633A1Anti-B7H3 antibody and Uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2023·Application pending·0 cites
- 1962US2012269817A1Monoclonal Antibodies Against Tissue Factor Pathway InhibitorWANG ZHUOZHI·Filed 2009·Application pending·0 cites
- 2060US2023008090A1A novel anti-cd3/anti-egfr bispecific antibody and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2020·Application pending·0 cites
- 2159US2025026833A1A bispecific anti-pd-l1/vegf antibody and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2022·Application pending·0 cites
- 2259US2017107298A1Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)BAYER HEALTHCARE LLC·Filed 2016·Application pending·0 cites
- 2357US9975962B2Thrombin/plasmin-regulated antibodies that bind TFPIBAYER HEALTHCARE LLC·Filed 2013·Granted May 22, 2018·0 cites·1 claims
- 2456US2018334509A1Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)BAYER HEALTHCARE LLC·Filed 2018·Application pending·0 cites
- 2555USRE49099EHumanized monoclonal antibodies against activated protein c and uses thereofBAYER HEALTHCARE LLC·Filed 2013·Granted Jun 7, 2022·0 cites·19 claims
- 2655US2024076411A1Multispecific antigen binding proteinsWUXI BIOLOGICS IRELAND LTD·Filed 2021·Application pending·0 cites
- 2754US2014294832A1Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)WANG ZHUOZHI·Filed 2012·Application pending·0 cites
- 2853US2017342162A1Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)BAYER HEALTHCARE LLC·Filed 2017·Application pending·0 cites
- 2952US2023242645A1A bispecific anti-pd-l1/vegf antibody and uses thereofWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 3052US2022348664A1A novel anti-pd-l1/anti-lag-3 bispecific antibody and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2020·Application pending·0 cites
- 3152US2018251570A1Protease-regulated antibodiesBAYER HEALTHCARE LLC·Filed 2018·Application pending·0 cites
- 3252US2018282430A1Anti-tfpi antibody variants with differential binding across ph range for improved pharmacokineticsBAYER HEALTHCARE LLC·Filed 2018·Application pending·0 cites
- 3349USRE47150EOptimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)BAYER HEALTHCARE LLC·Filed 2011·Granted Dec 4, 2018·0 cites·24 claims
- 3449US2022162312A1Novel bispecific cd3/cd20 polypeptide complexesWUXI BIOLOGICS IRELAND LTD·Filed 2020·Application pending·0 cites
- 3547US2021115138A1Novel bispecific pd-1/lag-3 antibody moleculesWUXI BIOLOGICS IRELAND LTD·Filed 2019·Application pending·0 cites
- 3646US2020354460A1Bispecific antibodies against EGFR and PD-1WUXI BIOLOGICS IRELAND LTD·Filed 2018·Application pending·0 cites
- 3746US2016009817A1Pro-drug antibodies against tissue factor pathway inhibitorBAYER HEALTHCARE LLC·Filed 2014·Application pending·0 cites
- 3846US2017210825A1Monospecific and multispecific antibodies and method of useBAYER IP GMBH·Filed 2017·Application pending·0 cites
- 3944US11365254B2Bispecific CD3/CD19 polypeptide complexesWUXI BIOLOGICS IRELAND LTD·Filed 2018·Granted Jun 21, 2022·0 cites·20 claims
- 4043US2021380710A1A novel anti-cd3/anti-cd20 bispecific antibodyWUXI BIOLOGICS IRELAND LTD·Filed 2019·Application pending·0 cites
- 4141US2015307625A1MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C (aPC)BAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhuozhi Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →